Systematic evaluation of personal genome services for Japanese individuals

Journal of Human Genetics

Volumn 58, Issue 11, 2013, Pages 734-741

  Kido, Takashi ^a,b   Kawashima, Minae ^c   Nishino, Seiji ^d   Swan, Melanie ^e   Kamatani, Naoyuki ^f   Butte, Atul J ^d  

^a Rikengenesis CO LTD   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MS Futures Group   (United States)

^f General Incorporated Association   (Japan)

Author keywords

Direct to consumer genetics; Disease risk prediction; Ethnicity; GWAS; Mathematical model; Personal genome; SNP; Systematic evaluation

Indexed keywords

ARTICLE; CALCULATION; ETHNICITY; GENETIC SCREENING; GENETIC SERVICE; GENOME; GENOME ANALYSIS; HUMAN; JAPANESE; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC TESTING; GENOME, HUMAN; HUMANS; PERSONAL HEALTH SERVICES; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT;

EID: 84888596561     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2013.96     Document Type: Article

References (16)

1. Dewey, F. E., Chen, R., Cordero, S. P., Ormond, K. E., Caleshu, C., Karczewski, K. J. et al. Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet. 7, e1002280 (2011
2. Hivert,M. F., Jablonski, K. A., Perreault, L., Saxena, R.,McAteer, J. B., Franks, P.W. et al. Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes 60, 1340-1348 (2011
3. Kamatani, Y., Matsuda, K., Okada, Y., Kubo, M., Hosono, N., Daigo, Y. et al. Genomewide association study of hematological and biochemical traits in a Japanese population. Nat. Genet. 42, 210-215 (2010
4. Miyake, K., Yang, W., Hara, K., Yasuda, K., Horikawa, Y., Osawa, H. et al. Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J. Hum. Genet. 54, 236-241 (2009
5. Morgan, A. A., Chen, R. & Butte, A. J. Likelihood ratios for genome medicine. Genome Med. 2, 30 (2010
6. Roberts, N. J., Vogelstein, J. T., Parmigiani, G., Kinzler, K. W., Vogelstein, B. & Velculescu, V. E. The predictive capacity of personal genome sequencing. Sci. Transl. Med. 4, 133ra158 (2012
7. Topol, E. J. Comment on 'the predictive capacity of personal genome sequencing'. Sci. Transl. Med. 4, 135le135. author reply 135lr133 (2012
8. Lyon, G. J. Personalized medicine: Bring clinical standards to human-genetics research. Nature 482, 300-301 (2012
9. Pierce, B. L. & Ahsan, H. Clinical assessment incorporating a personal genome. Lancet. 376, 869; author reply 869-870 (2010
10. Swan, M. Multigenic condition risk assessment in direct-to-consumer genomic services. Genet. Med. 12, 279-288 (2010
11. Zehnbauer, B. Direct-to-consumer genetics testing-fair comparisons? Clin. Chem. 57, 369-371 (2011
12. Ng, P. C., Murray, S. S., Levy, S. & Venter, J. C. An agenda for personalized medicine. Nature 461, 724-726 (2009
13. Bloss, C. S., Schork, N. J. & Topol, E. J. Effect of direct-to-consumer genomewide profiling to assess disease risk. N. Engl. J. Med. 364, 524-534 (2011
14. Steinthorsdottir, V., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Jonsdottir, T., Walters, G. B. et al. A variant in CDKAL1 influences insulin response and risk of type 2 diabetes. Nat. Genet. 39, 770-775 (2007
15. Imai, K., Kricka, L. J. & Fortina, P. Concordance study of 3 direct-to-consumer genetictesting services. Clin. Chem. 57, 518-521 (2011
16. Chen, R., Corona, E., Sikora, M., Dudley, J. T., Morgan, A. A., Moreno-Estrada, A. et al. Type 2 diabetes risk alleles demonstrate extreme directional differentiation among human populations, compared to other diseases. PLoS Genet. 8, e1002621 (2012